A Phase 1 Study of Carfilzomib-Thalidomide-Dexamethasone in Patients with Relapsed/Refractory AL Amyloidosis - Catalyst Trial Results

Metadata

Item Type:	Conference or Workshop Item
Authors/Creators:	Garg, M Hall, A Jenner, M Kishore, B Lachmann, HJ Gillmore, JD Pitchford, A Flanagan, L Oughton, JB https://orcid.org/0000-0002-2047-804X Mahmood, S Sachchithanantham, S Brown, SR https://orcid.org/0000-0002-7975-7537 Wechalekar, AD
Dates:	Published: 13 November 2019
Institution:	The University of Leeds
Depositing User:	Symplectic Publications
Date Deposited:	10 Jun 2021 13:01
Last Modified:	10 Jun 2021 13:01
Status:	Published
Identification Number:	10.1182/blood-2019-126567
Related URLs:	Author
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:169446

CORE (COnnecting REpositories)